பேட்ரிக் டூரிச் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பேட்ரிக் டூரிச். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பேட்ரிக் டூரிச் Today - Breaking & Trending Today

Calls intensify for Big Pharma to break monopolies on Covid-19 vaccines


Calls intensify for Big Pharma to break monopolies on Covid-19 vaccines
On February 25, Ivory Coast became the second country after Ghana to receive vaccines acquired through the UN-backed COVAX initiative with a delivery of 504,000 doses of the AstraZeneca vaccine made by the Serum Institute of India. Copyright 2021 The Associated Press. All Rights Reserved.
Pressure is mounting on countries to suspend intellectual property rules to help vaccines reach more people, especially in poorer countries, as quickly as possible. Can the new Director-General of the World Trade Organization break the deadlock?
This content was published on March 4, 2021 - 09:00
March 4, 2021 - 09:00
Last week Ghana became the first country to receive vaccine doses under COVAX – the vaccine pooling system that aims to ensure 20% of the population in every country receive vaccines. The first jabs in Ghana were a positive sign that rich countries won’t swallow up all the vaccines before ....

New York , United States , South Africa , Thomas Cueni , Patrick Durisch , Albert Bourla , Tedros Adhanom Ghebreyesus , Leena Menghaney , Ngozi Okonjo Iweala , Institute Of Technology , European Parliament , Associated Press , World Trade Organization , Swiss Mission , New York Times , Council Meeting , International Federation For Pharmaceutical Manufacturers , Technology Access Pool , Trade Related Aspects , Intellectual Property Agreement , International Federation , Pharmaceutical Manufacturers , General Thomas Cueni , Federal Institute , Medicines Law , Medicines Patent ,

Secret discounts leave patients at drugmakers' mercy


Secret discounts leave patients at drugmakers’ mercy
Some 63% of the drugs that received some kind of discount were cancer drugs. Keystone / Laurent Gillieron
A new study by the University of Zurich has found that using confidential discounts on cancer and other drugs does little to make them available faster and at more affordable prices. This comes amid debate over a plan to keep more drug prices under lock and key in Switzerland.
This content was published on February 19, 2021 - 11:00
February 19, 2021 - 11:00
Jessica Davis Plüss
Jessica covers the good, the bad, and the ugly when it comes to big global companies and their impact in Switzerland and abroad. She’s always looking for a Swiss connection with her native San Francisco and will happily discuss why her hometown has produced some of the greatest innovations but can’t seem to solve its housing crisis. ....

United Kingdom , Patrick Durisch , Merck Keytruda , Adrian Lobsiger , Ryan Tandjung , Kerstin Vokinger , Nora Kronig , World Health Assembly , World Health Organization , University Of Zurich , Switzerland This , Hodgkin Lymphoma , Swiss Federal Commissioner , Data Protection , Healthcare Policy , ஒன்றுபட்டது கிஂக்டம் , பேட்ரிக் டூரிச் , உலகம் ஆரோக்கியம் சட்டசபை , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , பல்கலைக்கழகம் ஆஃப் ஸுரி , சுவிட்சர்லாந்து இது , ஹாட்ஜ்கின் லிம்போமா , சுவிஸ் கூட்டாட்சியின் ஆணையர் , தகவல்கள் ப்ரொடெக்ஶந் , சுகாதாரம் பாலிஸீ ,